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Heteroresistance to the model antimicrobial peptide polymyxin B in the emerging 
Neisseria meningitidis linage11.2 urethritis clade: mutations in the pilMNOPQ operon 
 
Summary 
Clusters of Neisseria meningitidis (Nm) urethritis among primarily heterosexual males in 
multiple United States cities have been attributed to a unique non-encapsulated 
meningococcal clade (the U.S. Nm urethritis clade, US_NmUC) within the hypervirulent 
clonal complex 11. Resistance to antimicrobial peptides (AMPs) is a key feature of urogenital 
pathogenesis of the closely related species, N. gonorrhoeae.  The US_NmUC isolates were 
found to be highly resistant to the model AMP, polymyxin B (PmB, MICs 64-256 µg/ml). The 
isolates also demonstrated stable subpopulations of heteroresistant colonies that showed 
near total resistant to PmB (MICs 384-1024 µg/ml) and colistin (MIC 256 µg/ml) as well as 
enhanced LL-37 resistance.  This is the first observation of heteroresistance in N. 
meningitidis. Consistent with previous findings, overall PmB resistance in US_NmUC isolates 
was due to active Mtr efflux and LptA-mediated lipid A modification. However, whole 
genome sequencing, variant analyses and directed mutagenesis revealed that the 
heteroresistance phenotypes and very high level AMP resistance were the result of point 
mutations and IS1655 element movement in the pilMNOPQ operon, encoding the type IV 
pilin biogenesis apparatus. Cross-resistance to other classes of antibiotics was also observed 
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in the heteroresistant colonies. High-level resistance to AMPs may contribute to the 
pathogenesis of US_NmUC.  
Key words: Neisseria meningitidis, meningococcal urethritis, heteroresistance, polymyxin B, 
antimicrobial peptide, pilQ 
 
Introduction 
Neisseria meningitidis (Nm), an obligate human pathogen, is carried 
asymptomatically in the nasopharynx of 5-10% of adults and is transmitted by close contact 
with respiratory droplets of oral or nasal secretions.  Nm is also a leading cause of meningitis 
and rapidly fatal sepsis in otherwise healthy individuals that can cause large epidemic 
outbreaks (Rouphael & Stephens, 2012, Stephens et al., 2007). While capsular 
polysaccharide conjugate and protein-based meningococcal vaccines provide protection, 
invasive meningococcal disease is a continued worldwide problem. 
Nm and Neisseria gonorrhoeae (Ng) are the only two Neisseria species that are 
human pathogens and these organisms most commonly colonize respiratory and urogenital 
tracts, respectively. Historically, Nm has not been a significant cause of urogenital disease 
and was infrequently recovered from the urogenital tract (cervix, vagina, and urethra) and 
rectum. However, there have been sporadic case reports in which Nm was isolated from 
patients with urethritis, cervicitis, vaginitis, proctitis, pelvic inflammatory disease, and 
postpartum endometritis dating back to the 1940s (Givan et al., 1977, Conde-Glez & 
Calderon, 1991, Maini et al., 1992). Recently, sustained sexually transmitted meningococcal 
urethritis outbreaks have been reported (Bazan et al., 2016, Bazan et al., 2017, Toh et al., 
2017, Tzeng et al., 2017, Retchless et al., 2018). In one study, seventy-five Nm urethritis 
cases detected between January and November of 2015 in Columbus OH, represented 20% 
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of all men who presented during that time with urethral GNID and growth of oxidase-
positive Gram-negative diplococci (Bazan et al., 2017).  Similar Nm-associated urethritis 
clusters have now been observed in multiple U.S. cities (Bazan et al., 2016, Bazan et al., 
2017, Toh et al., 2017, Retchless et al., 2018). These urethritis-associated Nm isolates are 
members of a novel nongroupable US Nm urethritis clade (US_NmUC) in the cc11/ET-15 
hyperinvasive lineage (Tzeng et al., 2017).  The US_NmUC isolates do not make capsules 
(Toh et al., 2017, Tzeng et al., 2017) due to an IS1301 insertion that caused a multi-gene 
deletion at the capsule biosynthesis locus (Tzeng et al., 2017).  Unlike many Nm isolates, the 
US_NmUC isolates are capable of efficient nitrite dependent anaerobic growth. This is due 
to a gene conversion event that introduced gonococcal aniA-norB genes, which encode 
enzymes that catalyze conversion of nitrite to nitric oxide and then nitrous oxide (Tzeng et 
al., 2017). Thus, the emergence of US_NmUC as a urethritis pathogen is likely the result of 
multiple evolutionary genetic events that allow better assimilation into the same niche first 
adopted by gonococci (Tzeng et al., 2017, Retchless et al., 2018). 
Resistance to host-derived antimicrobial peptides (AMPs) is a key feature of 
neisserial pathogenesis at mucosal surfaces (Johnson & Criss, 2011, Tzeng & Stephens, 
2015). A hallmark of gonococcal (and meningococcal) urethritis is the influx of PMNs, which 
employ both oxidative (production of reactive oxygen species) and non-oxidative (release of 
AMPs) killing mechanisms (Johnson & Criss, 2011, Criss & Seifert, 2012). In both Nm and Ng, 
resistance to PMN- derived and epithelial derived AMPs is mainly due to the activity of the 
LptA-mediated lipid A modification by phosphoethanolamine and the Mtr efflux pump 
(Tzeng et al., 2005). We have previously performed mariner random mutagenesis screening 
and identified transposon mutants in pilM and pilP that increased AMP resistance (Tzeng et 
al., 2005). In this report we show that the US_NmUC isolates are highly resistant to the AMP 
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polymyxin B (PmB), a well-recognized surrogate for endogenous AMPs, and also exhibit 
“heteroresistance” (subpopulations of higher resistant colonies in the zone of inhibition) to 
PmB and colistin (polymyxin E).  Increased AMP resistance of these isolates is linked to 
mutations in pilM and pilQ. PilQ is a member of the secretin family of proteins, and a major 
component of the outer membrane (Berry et al., 2012). PilM is a cytoplasmic ATP-binding 
protein that together with PilN/O/P proteins forms the inner membrane platform of the 
type IV pilus biogenesis complex (Ayers et al., 2009). Nm heteroresistance selected by PmB 
exposure, in addition to enhance resistance to colistin and LL-37, also conferred cross-
resistance to several antibiotics, suggesting entry of these antibiotics is PilQ dependent. 
Heteroresistance to PmB has been described in several other Gram-negative bacterial 
pathogens, (Li et al., 2006, Lo-Ten-Foe et al., 2007, Hermes et al., 2013, Hjort et al., 2016, 
Jayol et al., 2015, El-Halfawy & Valvano, 2013) but this is the first demonstration of this 
phenomenon in Neisseriae. 
 
Results 
US_NmUC isolates demonstrate heteroresistance to polymyxin B and colistin 
AMP resistance is an important pathogenic trait for both Ng and Nm. PmB E-test 
strips were used to determine the PmB MICs and revealed that the non-encapsulated 
US_NmUC isolates were highly resistant (Supplemental Table S1; Figure 1A). Of 52 CNM 
isolates, 41 (79%) had PmB MIC of 128-256 µg/ml and MICs of 10/11 remaining isolates 
were 64-96 µg/ml. One isolate, CNM34, had a significantly lower PmB MIC (16 µg/ml). 
Whole genome analysis of this isolate revealed a 2-bp deletion in mtrC, which encodes a key 
component of the Mtr efflux pump (Shafer et al., 1998). Two US_NmUC isolates from 
Atlanta had MICs of 96 and 128 µg/ml, respectively (Table S1). For comparison, the PmB 
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MIC of a well-characterized unencapsulated meningococcal M7 strain (Swartley & Stephens, 
1994, Tzeng et al., 2005) is 64 µg/ml. The PmB MICs of a clinical gonococcal isolate 
recovered during the Columbus urethritis outbreak (CNG20) and two gonococcal reference 
strains (FA19 and FA1090) were 48, 48 and 96 µg/ml, respectively; while the PmB MIC of a 
multi-drug resistant (MDR) gonococcal isolate from Japan, H041, (Ohnishi et al., 2011) is 192 
µg/ml. These data suggest that the non-encapsulated US_NmUC isolates display equal or 
greater AMP resistance than gonococci.  
Many of the US_NmUC isolates displayed PmB heteroresistance (Li et al., 2006, Lo-
Ten-Foe et al., 2007); i.e., they yielded subpopulations of highly PmB resistant colonies in 
the zone of inhibition in disc diffusion and E-test assays (e.g. CNM3 shown in Figure 1A). 
These isolates also yielded higher MIC values in microbroth dilution assays. For example, the 
PmB MIC of CNM3 was 256 µg/ml by E-test, but was 1,024 µg/ml using the microbroth 
dilution assay. In contrast, neither the gonococcal strains tested nor M7 exhibited 
heteroresistance. However, during E testing, we did observe heteroresistant colonies of 
FAM18, a serogroup C cc11 reference strain, and a serogroup W cc22 invasive isolate 
GA18736 from Georgia (E-test pictures shown in supplemental figure 1), indicating that 
heteroresistance in Nm is not only found in US_NmUC isolates. 
Heteroresistance of the US_NmUC isolates was confirmed using population analysis 
profiling (PAP) assays (El-Halfawy & Valvano, 2015).  CNM3, CNM8 and the non-
encapsulated FAM18 derivative FM7 was not eliminated by > 16-fold increases in PmB 
concentration (Figure 1B). In contrast, growth inhibition of M7 and FA1090 occurred across 
a narrow PmB concentration range. MC58 and FA19 also did not exhibit heteroresistance 
(data not shown). Interestingly, although CNM8 and FM7 failed to form colonies in the zone 
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of inhibition in E tests (Figure 1A), these strains were heteroresistant in the PAP assay 
(Figure 1B).  
We also examined whether the isolates exhibiting PmB heteroresistance would 
display analogous phenotypes toward another clinically used AMP, colistin (polymyxin E).  
As shown in Figure 1C, CNM3 and FM7 displayed the heteroresistance profile toward 
colistin; while the growth of M7 and FA1090 was inhibited across a narrow range. These 
data were consistent with the PmB resistance profiles of these strains.  Further, the colistin 
E-test of CNM3 also showed colonies within the zone of inhibition (insert in Fig. 1C).   
Heteroresistance to PmB is stable in US_NmUC isolates 
Heteroresistance to PmB, colistin and other antimicrobial agents in some bacteria is 
transient and reverts in the absence of continuous antimicrobial pressure (Napier et al., 
2014, El-Halfawy & Valvano, 2015). To test if heteroresistance in the US_NmUC isolates was 
reversible, colonies picked from the zones of inhibition of CNM isolates (Table 1) were 
repeatedly passed on GCB agar plates in the absence of PmB. The elevated PmB MICs of 
these colonies were retained, suggesting that their enhanced PmB resistance was stable and 
likely due to genetic change(s). One of the recovered heteroresistant mutants, 3R4, was 
examined for resistance to colistin using PAP and E-test. The mutant was more resistant to 
colistin with a MIC greater than 256 µg/ml, whereas the MIC of the parental isolate CNM3 
to colistin was ~ 48-64 µg/ml (Figure 1C). The resistance to LL-37 was also compared. The 
strains were treated with varying concentrations of LL-37 for 30 min followed by plating for 
viable CFU counts.  The 3R4 mutant was more resistant to LL-37 in all concentrations tested 
than the parental strain (Figure 2), thus supporting the hypothesis that PmB 
heteroresistance confers cross-resistance to host endogenous antimicrobial peptides. 
Identification of heteroresistance associated mutations using genome sequencing  
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Genomes of eight heteroresistant colonies (3R3, 14R2, 17R1, 32R1, 32R2, 33R1, 37R1 
and 45R2) derived from 7 CNM isolates (first number in strain designation is the parental 
CNM number, Table 1) were sequenced. Variants were identified by aligning the raw 
sequence reads against a CNM10 reference genome using PATRIC (www.patricbrc.org). 
Separately, assembled contigs were also compared to the CNM10 genome using the 
genome comparator (www.pubmlst.org). 
Variants (Supplemental Data set S1) were examined for genes with previously 
reported roles in antimicrobial resistance. Alterations in several pil genes were identified in 
multiple heteroresistant mutants, pilU (33R1), pilM (45R2), pilQ (14R2, 17R1) and the pilS 
cassettes (silent incomplete pilin coding fragments responsible for antigenic variation of 
PilE) (17R1, 32R1, 32R2, 33R1 and 37R1) (Supplemental Data set S1). The class II pilE gene 
encoded near katA was intact in all mutants. Multiple repeated sequence motifs and slipped 
strand mispairing (SSM) events were detected, but none of these were in loci with known 
roles in AMP resistance.  Overall, point mutations in pilM or pilQ were identified in seven of 
the eight heteroresistant mutants; while pilM is disrupted by an IS element in the remaining 
mutant (Table 1).  
Frameshift mutations were identified in pilQ in the 3R4, 32R1, 32R2 and 33R1 
mutants. 3R4 had a deletion (T) at position 167 that resulted in a premature stop at residue 
57. Five additional colonies recovered from CNM3 (3R4-3R7) in independent experiments 
had the same deletion. 32R1 and 32R2 were isolated from CNM32 and both had a 1-bp 
insertion (G) at position 2229 that extended the PilQ coding region (815 aa vs. 769 aa). 33R1 
had a 1-bp deletion (A) at position 1947 that truncated PilQ from 769 to 655 residues. The 
insertion in 32R1 changed a G3 to a G4 track and the deletion in 33R1 resulted in an A6-to-A5 
transition. Whether these two short homopolymeric tracks have an increased sequence 
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instability associated with the slipped strand mispairing phase variation events is not clear 
(Saunders et al., 2000, Snyder et al., 2001). The 14R2 and 17R1 mutants had C-A conversions 
at positions 2266 and 1465 that resulted in T to P residue changes at residue 756 and 489, 
respectively. Since the pilQ frameshift and these missense mutations yielded high levels of 
PmB resistance (MIC 1,024 µg/ml), these observations suggest that the missense mutations 
in 14R2 and 17R1 likely disrupt PilQ’s function as a multimeric protein complex. Two 
mutants had mutations in pilM, the first gene in the pilMNOPQ operon (Carbonnelle et al., 
2005). 45R2 had a C-T conversion that resulted in a stop codon at residue 44; while pilM in 
37R1 was disrupted by an IS1655 insertion at position 16. The pilM mutants had lower PmB 
MICs (256-512 µg/ml) than the pilQ mutants. 
To further evaluate the effects of various pilQ and pilM mutations, we performed 
PilQ Western blots on total cellular extracts of the heteroresistant mutants and the wild 
type strain. As shown in Figure 3, a high molecular weight multimer band, a monomer band 
and several smaller bands, presumably degraded products, were detected by the PilQ 
monoclonal antibodies, like the previously reported pattern (Nandi et al., 2015).  The pilQ 
frameshift mutants (3R4 and 33R1) resulting in premature truncation eliminated both of 
multimer and monomer bands (lanes 2 and 8). A weak and larger monomer band was 
detected for 32R1 (lane 7), in which the frameshift mutation resulting in a predicted larger 
protein; however, no multimer band was detected in this mutant.  Two mutants with pilQ T 
to P residue changes (14R2 and 17R1) yielded no multimer bands, while maintaining 
monomer bands at comparable intensities as the wild type strain (lanes 5 and 6).  Finally, 
the pilM::IS1655 mutant (37R1) and the pilM frameshift mutant (45R2) showed reduced 
levels of PilQ in both multimer and monomer forms (lanes 3 and 4), indicating a probable 
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polar effect on PilQ protein expression, a phenomenon also observed in gonococci (Nandi et 
al., 2015). 
Independent pilM and pilQ mutations conferred enhanced PmB resistance 
 We previously showed that separate mariner transposon mutants in pilM and pilP 
caused increased PmB resistance (Tzeng et al., 2005). Transferring the pilM::aphA3 mutation 
into CNM3 was sufficient to increase the PmB MIC and the introduction of pilQ::aphA3 into 
CNM3 also conferred the higher PmB MICs observed in pilQ frame shift mutants. To 
independently confirm the effects of pilQ T→P point mutations, constructs with the 
aphA3(KnR) cassette inserted immediately downstream of the pilQ stop codon and carrying 
14R2 or 17R1 point mutations in pilQ were generated. Five transformants were sequenced. 
All five CNM3-14R2 transformants carried the expected mutation via homologous 
recombination, whereas 2 of 5 CNM3-17R1 transformants contained the desired mutation. 
E-tests confirmed that the transformants carrying the T→P mutation have enhanced PmB 
resistance (Supplemental Figure 1), while PmB MICs of the transformants with a wild type 
pilQ sequence were identical to that of CNM3. Introducing these mutations in the respective 
parental isolate (CNM14 and CNM17) also produced the same PmB resistance results as the 
original mutants. 
The pilM and pilQ mutations reduced transformation efficiency 
Disruption of type IV pilin biogenesis apparatus is known to cause competence 
deficiency (Georgiadou et al., 2012). Thus, we expected the PmB heteroresistant mutants to 
have defects in transformation efficiency. Transformation efficiencies of the mutants were 
examined using chromosomal DNA carrying a tonB::Ω(Sp) mutation. As show in Table 1, all 
parental isolates showed transformation efficiency in the range of 10-4 – 10-5 per µg DNA. 
Significant reductions (>3 logs) were observed in all PmB resistant mutants. Most of the 
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mutants were not transformable. The 17R1 (PilQ/T489P) mutant and the 33R1 mutant with 
a truncated PilQ remained transformable but with a 2-order of magnitude reduction in 
efficiency. Despite the differences in transformation efficiency, all pilQ mutations yielded 
similar higher levels of PmB resistance than the pilM mutants, both mutants were 
incompetent in transformation. There was no correlation between PmB resistance and 
transformation phenotypes. 
Heteroresistance requires the Mtr efflux pump and the LptA transferase 
 N. meningitidis intrinsic PmB resistance is mediated by LptA-mediated lipid A 
modification with phosphoethanolamine, the Mtr efflux pump and the capsule (Tzeng et al., 
2005, Spinosa et al., 2007, Jones et al., 2009). To test if heteroresistance required these 
mechanisms, we introduced mtrD or lptA mutations in CNM3.  Inactivation of mtrD and lptA 
reduced the PmB MIC levels to 24-32 µg/ml and 0.1 µg/ml, respectively (E-test data shown 
in supplemental figure 1). Neither mutants formed heteroresistant colonies in E-test and 
disc diffusion assays. In addition, PAP assays showed no heteroresistance toward PmB or 
colistin in the mtrD mutant (CNM3D) (Figure 4). Thus, development of heteroresistance in 
these strains is dependent upon intrinsic determinants of PmB resistance (Tzeng et al., 
2005).  
The US_NmUC isolates did not have higher spontaneous mutation or slipped strand 
mispairing frequencies 
  The number of point mutations and changes in monomeric tracks we observed 
suggested that the heteroresistant isolates might have higher mutation rates.  We examined 
the spontaneous mutation rate in CNM3 using rifampin plating assays. The spontaneous 
rifampin resistance rate of CNM3 was low (median 2.2×10-10) and comparable to a low 
switcher strain IR2781 (median 1.7×10-9) (Richardson & Stojiljkovic, 2001). For comparison, 
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IR2855, a mutL mutator strain that has a ~1000-fold higher mutation rate (median 3.7×10-7) 
than CNM3, exhibited a PAP profile similar to CNM3 (Figure 4A). The DNA mismatch repair 
(MMR) pathway is an important determinant of overall mutability and phase variation 
frequency in Nm (Richardson & Stojiljkovic, 2001). We generated a mutL mutation in CNM3 
(CNM3L) to test if heteroresistance was influenced by the MMR pathway. The spontaneous 
rifampin resistance rate in CNM3L was more than 100-fold higher compared to CNM3 but 
these strains had similar PAP profile (Figure 4A). Thus, the MMR system did not appear to 
have a major role in the PmB heteroresistance phenotype.  
Interestingly, it has been reported that cationic antimicrobial peptides, LL-37 and 
colistin, increased iron-induced mutagenesis in P. aeruginosa (Limoli et al., 2014, Rodriguez-
Rojas et al., 2015). As we have performed experiments using iron-rich GC media, it was 
plausible that the heteroresistant mutations were enhanced in the presence of PmB and 
possibly other AMPs in N. meningitidis. We examined whether the antimicrobial peptide 
affected mutagenic phenotype in the clade isolate by comparing spontaneous rifampin 
mutation rates of meningococci grown on standard GC plates (Fe+3 is supplemented at 12 
µg/ml) with or without colistin at 128 or 256 µg/ml (MIC50 as determined by the PAP assay is 
~128 µg/ml).  When compared to meningococci grown in the absence of colistin, no 
significant increases in spontaneous rifampin mutation rates upon exposure to colistin 
under the iron-replete condition were observed (data not shown).  
 We also measured the frequency of slipped-strand mispairing using the universal 
rate of switching cassette (UROS) assay (Alexander et al., 2004b). The UROS cassette 
contains a poly (G)8 tract within the Ω(Sp) cassette of aadA that is in the off phase. Thus, SpR 
colonies form when aadA is switched into the on phase by slipped strand mispairing. The 
UROS cassette did not show a higher slipped strand mispairing rate in CNM3, when 
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compared to that of strain IR5426, (UROS cassette in the high switcher/mutator IR2855) 
(Alexander et al., 2004b).  
PmB heteroresistant mutants have reduced susceptibility to multiple antibiotics 
We tested if the resistance to other antimicrobial agents was altered in the PmB 
heteroresistant mutant 3R4, using E-tests (Table 2) and disc diffusion (supplemental table 2) 
on GC agar plates. CNM3 and 3R4 had similar susceptibility to levofloxacin, meropenem and 
azithromycin, which is one of the two current standards of care antibiotic treatment for 
gonorrhea. However, 3R4 has reduced susceptibility to penicillin G, ceftriaxone, cefotaxime, 
streptomycin, kanamycin, chloramphenicol and tetracycline (Table 2). The resistances of 
3R4 to ceftriaxone and cefotaxime were two-fold higher than CNM3 by E-test, although its 
MICs remained in the sensitive range (Table 2). Interestingly, CNM3 has reduced 
susceptibility to several antibiotics such as azithromycin, meropenem, penicillin, and 
cefuroxime when compared to the Ng reference strain FA19 and to a clinical isolate CNG20. 
The resistance of CNM3 to penicillin G, cefuroxime and azithromycin was like that of the 
gonococcal isolate MS11, which has elevated resistance due to the presence of the penA, 
mtrR, and penB mutations (Ropp et al., 2002, Ohneck et al., 2011). Thus, the pilQ defect in 
the PmB heteroresistant mutant indeed influenced, albeit modestly, the susceptibility to 
many unrelated antibiotics. 
Altered resistances to penicillin G, chloramphenicol and tetracycline between CNM3 
and 3R4 were also compared in the mtrD and the lptA mutant backgrounds and no 
differences were observed in these backgrounds (Table 3). These data suggest that the 
higher intracellular antibiotic levels caused by either efflux pump inactivation (mtrD) or 
compromised membrane integrity (lptA) cannot be effectively reduced by blocking 
antibiotic entry through a pilQ mutation.  
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Discussion 
The US_NmUC has emerged as urogenital pathogen. Historically, Nm is not 
recognized as a significant cause of urogenital infection and the occasional meningococci 
recovered from such isolated cases have been from diverse serogroups and lineages 
(Harrison et al., 2017, Ma et al., 2017). The recent urethritis outbreaks and clusters caused 
by US_NmUC suggest that with novel genetic and phenotypic changes, this meningococcal 
clade is being transmitted efficiently between sexual partners and can successfully resist 
local innate immune responses (Bazan et al., 2016, Tzeng et al., 2017, Bazan et al., 2017, 
Toh et al., 2017, Retchless et al., 2018).  
 
Like N. gonorrhoeae, the US_NmUC isolates trigger a potent local inflammatory 
response characterized by urethral discharge and presence of many polymorphonuclear 
leukocytes (PMNs) in the inflammatory exudates (Johnson & Criss, 2011). These US_NmUC 
isolates exhibited bacterial resistance to host killing. In this report, we investigate the basis 
of high-level resistance to AMPs of these US_NmUC isolates. Resistance to host-derived 
AMPs is an important pathogenic trait for both Ng and Nm (Johnson & Criss, 2011). Recent 
studies have indicated that PMNs primarily direct non-oxidative antimicrobial activities 
against Ng (Johnson & Criss, 2011). Non-encapsulated Nm and Ng are generally more 
sensitive to the action of AMPs than encapsulated meningococci (Tzeng et al., 2005). The 
ability of US NmUC isolates to resist killing by human AMPs, either produced locally by the 
mucosal epithelia where they serve as a primary defense mechanism or to resist AMP-
mediated non-oxidative killing by PMNs at this site, may have important advantages. 
Survival in PMN’s may also serve as vehicles for dissemination in urethral exudates. Many of 
the non-encapsulated US_NmUC isolates displayed greater PmB resistance (MICs 96-256 
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µg/ml) than Ng and considerable higher resistance (MICs 384-1,024 µg/ml) was observed for 
the heteroresistant subpopulations.  
Heteroresistance to PmB or colistin has been described in Acinetobacter baumannii 
(Li et al., 2006), Enterobacter cloacae (Lo-Ten-Foe et al., 2007), P. aeruginosa (Hermes et al., 
2013), Salmonella typhimurium (Hjort et al., 2016), Klebsiella pneumonia (Jayol et al., 2015, 
Band et al., 2018) and Burkholderia cenocepacia (El-Halfawy & Valvano, 2013) and can lead 
to treatment failure in clinical settings and in experimental models (Band et al., 2016, Band 
et al., 2018). Interestingly, the PmB heteroresistant subpopulation of B. cenocepacia can 
protect the more sensitive B. cenocepacia population as well as sensitive P. aeruginosa and 
Escherichia coli from killing by PmB and various bactericidal antibiotics (El-Halfawy & 
Valvano, 2013). However, heteroresistance to AMPs has not been previously reported for 
Neisseria. Further, we found that meningococcal heteroresistance was not transiently 
induced upon exposure to AMPs (Napier et al., 2014), but was instead stable in the absence 
of PmB, and we have identified the genetic alteration(s) aiding PmB resistance.  
Mutations in the pilin biogenesis apparatus appear to restrict the entry of PmB and 
other antimicrobial agents, and responsible for heteroresistance in Nm. PilQ secretin, in 
addition to promoting pilin biogenesis and DNA transformation, facilitates the entry of small 
molecules into the bacterial cell. High-level heteroresistance to PmB can produce cross-
resistance to several other important antimicrobial agents [Table 2 and (Napier et al., 
2014)]. The increase in MICs of PmB and to a variety of antibiotics in the heteroresistant 
mutants compared to the wild type strain are consistent with those observed in gonococcal 
pilQ mutants (Chen et al., 2004, Zhao et al., 2005, Johnson et al., 2014), highlighting the 
importance of a functional PilQ in the entry of antibiotics. 
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PilQ facilitates the entry of a variety of antibiotics in the gonococci, including 
penicillin, ceftriaxone, vancomycin, tetracycline, rifampin, and ciprofloxacin (Ropp et al., 
2002, Zhao et al., 2005, Nandi et al., 2015). An in vitro spontaneous mutation screen of two 
gonococcal isolates containing mosaic penA sequence with MICs to ceftriaxone ranging from 
0.03 to 0.06 µg/ml identified mutants with increased MICs to ceftriaxone almost 10-fold (0.5 
µg/ml).  Genetic analysis showed an identical 2-bp insertion in pilQ in each of the mutants 
(Johnson et al., 2014). Further, spontaneous penicillin resistant gonococcal clones were 
selected at a frequency of ~10-6 and all had a non-piliated morphology (Nandi et al., 2015). 
The mutations were found to be clustered within the C-terminal domain (residue 400 to 
731) of PilQ and all pilQ mutants increased the MIC of penicillin by 2.5- to 3-fold (Nandi et 
al., 2015).  
 
Of the five gene mutations known to contribute to high-level penicillin resistance in 
Ng (Ropp et al., 2002), penB, mtrR and pilQ2, have been shown to also play a role in PmB 
susceptibility (Tzeng et al., 2005). The pilQ2 allele is an E666K point mutation in pilQ (Zhao 
et al., 2005). Interestingly, the increased resistance due to acquisition of the pilQ2 mutation 
is observed only in strains containing the mtrR and penB resistance determinants (Zhao et 
al., 2005). The diffusion of antibiotics through PilQ become significant only when influx 
through porins is limited due to disruptions in the porin gene (penB) or up-regulation of Mtr 
pump efflux (mtrR), (Zhao et al., 2005). Similarly, diffusion of antibiotics through PilQ is likely 
only a small fraction of the antibiotic influx in N. meningitidis, as reflected by the modest 
changes in MIC values in the heteroresistant mutants. We observed that the pilQ mutations 
caused enhanced PmB resistance only in the wild type background. When resistance levels 
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were reduced ~4-8 fold by mutations in the Mtr efflux pump, we did not observe any clear 
difference in PmB resistance with the combined pilQ/mtr mutation.  
Defects in the mismatch repair (MMR) pathway responsible for removing 
insertion/deletion loops (Lahue et al., 1989) have generally been associated with 
meningococcal mutator phenotype (Richardson & Stojiljkovic, 2001, Richardson et al., 
2002). Since PmB resistant mutants due to frameshift and point mutations in pilQ and pilM 
were recovered readily from the heteroresistant clade isolates, a possible mutator 
phenotype and a defect in MMR pathway was explored. Nevertheless, the clade isolates did 
not show enhanced mutation rate using the standard spontaneous rifampin resistance 
plating assay and have relatively low slipped strand mispairing rates. We examined the 
contribution of the MMR pathway by introducing a mutL mutation, and confirmed that no 
effect on heteroresistance was detected in the mutL mutant. However, the standard 
rifampin plating assay that measures the spontaneous mutation rate in the essential rpoB 
gene, encoding a subunit of RNA polymerase, is likely constrained to only detect the rate 
yielding viable mutants. Thus, it is possible that the mutation rates obtained with rifampin 
resistance do not reflect the rates of those mutations needed for antimicrobial peptide 
resistance. Antimicrobial peptides such as colistin and LL-37 have been reported to enhance 
mutation rates in P. aeruginosa (Limoli et al., 2014, Rodriguez-Rojas et al., 2015). However, 
we did not detect significant changes in rifampin mutation rates when meningococci were 
grown on iron-rich GC agar plates in the presence of colistin, a condition shown to influence 
mutagenic phenotype in P. aeruginosa (Rodriguez-Rojas et al., 2015). 
Other repair pathways correcting DNA lesions include the base excision repair (BER) 
(MutY, Fpg/MutM, Nth), the nucleotide excision repair (NER) (UvrA/B/C), the 
recombinational repair (RecA/B/C/D), and translesion synthesis (DinB) (Davidsen et al., 
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2007b). Several of these DNA repair proteins and others have been characterized to 
influence mutation rates (Alexander et al., 2004a, Martin et al., 2004, Davidsen et al., 
2007b, Davidsen et al., 2007a), thus additional studies are needed to have a detailed 
understanding about the contribution of other DNA repair pathways in the development of 
heteroresistance.   
The 37R1 heteroresistant mutant had a pilM disruption by a newly inserted IS1655. 
IS1655 is a 1080-bp long element that would generate a 3-bp target duplication upon 
insertion (Kiss et al., 2007), which was indeed observed in 37R1. A whole genome 
comparison study of disease and carriage strains has suggested that Nm can be separated 
from Neisseria lactamica and Ng based on the respective IS repertoires and that IS1655 is 
restricted to Nm (Schoen et al., 2008). The authors noted that none of the six Nm strains 
analyzed have IS1655 at the same chromosomal location, suggesting a high mobility of 
IS1655. Inspecting the complete genome of the US_NmUC isolate CNM10, we found 11 
intact copies and one truncated copy of IS1655. As a comparison, the serogroup B strain 
MC58 has 14 copies; while the cc11 reference FAM18 has 9 intact and 1 truncated copies. 
Since the genome of 37R1 had multiple contig breaks, it is uncertain whether 37R1 has the 
same copy number of IS1655 as CNM10. 
Because the pilin biogenesis mutations disrupt normal piliation, the increases in AMP 
resistance because of such mutations might not be biologically significant, considering the 
importance of pili in colonization and infections. However, mutations in pilQ have been 
shown to result in complex phenotypes (Helm et al., 2007), it is possible that certain pilQ 
mutations allow for increased AMP resistance and retain pathogenic potential. Interestingly, 
experimental infections of male volunteers using a nonpiliated gonococcal pilE mutant 
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showed that the pilus was not required for infection, although the symptoms were less 
severe in infections with the nonpiliated variant (Hobbs et al., 2011).  
Ng has been proposed to have originated from Nm, a pharyngeal colonizer that 
switched to primarily colonizing the urogenital tracts, resulting in lower frequency of gene 
flow between Nm and Ng due to ecological separation within the human host (Vazquez et 
al., 1993). The ability of US_NmUC isolates to withstand killing by AMPs produced either by 
epithelial cells or by PMNs is likely an important selective advantage and requirement for 
dissemination in urethral exudates. Further, the ability of the clade isolates to effectively 
colonize the urogenital tract raises the concern of horizontal gene transfer of antimicrobial 
resistance determinants, considering the wide-spread antimicrobial resistance in Ng 
(Unemo & Shafer, 2014).  US_NmUC isolates are intermediate in sensitivity to penicillin, 
sensitive to azithromycin and ceftriaxone and have uniformly responded to gonococcal 
treatment regimens. However, the heteroresistance phenotype further demonstrates the 
propensity for enhanced antibiotic resistance by spontaneous mutations of the pilin 
biogenesis genes and/or IS movement in this clade. Based on emergence of antibiotic 
resistance in the gonococcus, we will continue to need to monitor the antimicrobial 
resistance of this novel meningococcal urethritis clade. 
 
Experimental Procedures 
Bacterial isolates and growth conditions   
Bacterial strains used in this study are listed in Table 4. These stains included 52 N. 
meningitidis urethritis clade isolates collected from men between January 2015 and 
September 2015 at Columbus Public Health (CPH), Columbus, Ohio (Tzeng et al., 2017) with 
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the CNM3 isolate being the major representative of this collection. The initial demographic 
features of these cases and the collection protocol have been previously reported (Bazan et 
al., 2016, Bazan et al., 2017). Two additional clade isolates from Atlanta, Georgia, ATL#1 and 
ATL#2, a serogroup A isolate, IR2855, a serogroup W clinical isolate, GA18736, as well as 
genetically defined derivatives of well-characterized N. meningitidis strains IR2781 (NMB) 
(Stephens et al., 1991) and FAM18 were also used.  One gonococcal isolate (CNG20) 
recovered from the same period and gonococcal reference strains, FA19, FA1090, MS11 and 
H041 were also used for comparisons. Neisseria were cultured with 5% CO2 at 37°C on GC 
base (GCB; Difco) agar containing supplements of 0.4% glucose and 0.68 mM Fe(NO3)3, or 
GC broth with the same supplements and 0.043% NaHCO3. Brain heart infusion (BHI) 
medium with 1.25% fetal bovine serum was used when kanamycin selection was required. 
Escherichia coli strains were routinely grown in Luria Bertani broth for cloning and 
propagation of plasmids. N. meningitidis was transformed by the procedure of Janik et al. 
(Janik et al., 1976).  E. coli strains were transformed by chemical competence or by 
electroporation with a GenePulser (Bio-Rad) according to the manufacturer’s protocol.  
When necessary, Neisseria (E. coli) were grown in the presence of antibiotic concentrations 
(μg/ml): kanamycin (Kn) 80 (50), chloramphenicol, 5 (34), tetracycline, 5 and spectinomycin 
(Sp), 60 (100). 
 
Susceptibility assays 
The minimum inhibitory concentrations of PmB and antibiotics were determined by 
E test. Cell suspensions from overnight GC plates adjusted to OD550 of 0.3 were swabbed 
onto GC agar plates. Discs soaked with 10 µl of PmB solutions (25.6 mg/ml) or discs with 
defined levels of antibiotics (BBL) were overlaid and the plates were incubated overnight at 
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37°C in 5% CO2. E test strips (bioMerieux) were performed in a similar fashion. MIC values of 
PmB were reported as μg/ml. Microbroth dilution assays using 96-well microtiter plates 
were performed using GC broth with standard supplements. Two-fold serial dilutions of 
PmB concentrations starting at 1,024 µg/mL were tested. The sensitivity to LL-37 was 
determined using 96-well microtiter plate.   
 
Population analysis profiling (PAP) assays 
Overnight plate cultures of meningococcal strains were resuspended in GC broth and 
adjusted to optical density of 0.3 at 550 nm. Ten-fold serial diluted bacterial suspensions 
were prepared and duplicate aliquots of 40 µl of suspensions were spotted onto GC agar 
plates with 2-fold incremented concentrations of polymyxin B. Bacterial growth at each of 
these concentrations is quantified by CFU count after overnight incubation. An isolate would 
be considered heteroresistant when the lowest antibiotic concentration giving maximum 
growth inhibition is >8-fold higher than the highest non-inhibitory concentration (El-Halfawy 
& Valvano, 2015). 
 
Western blot  
Expression of PilQ in whole-cell extracts was examined by Western blot. Briefly, strains 
grown on GC plates overnight at 37°C were collected by centrifugation. Whole cell lysates of 
equal cell densities were prepared in SDS loading buffer, resolved by 8% SDS-PAGE, and 
transferred to nitrocellulose membranes by semi-dry transfer. The antisera against PilQ 
(Tonjum et al., 1998) were used at 1:5000 dilutions and anti-rabbit IgG-HRP conjugate 
secondary antibody (Bio-Rad) was used at 1:10,000 dilution. The blot was developed using a 
1:5 dilution of pico chemiluminescent substrate (Pierce). 
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LL-37 killing assay 
Overnight cultures were harvested into RPMI and adjusted to OD550 of 0.3. The 
standardized suspensions were diluted 100-fold and then 50-fold to have approximately 105 
CFU/ml. Each assay was started by the addition of 90 µl of cells into a well containing 10 µl 
of LL-37 to reach the desired final concentrations, 1.25 to 10 µg/ml. The microtiter plate was 
incubated at 37°C and 5% CO2. Two 20-µl aliquots of the sample were removed after 30 min 
and the number of viable CFU were determined by plating onto GC agar plates. Experiments 
were performed in duplicate wells on several occasions. Student’s t test was used to 
determine the statistical significance of survival of the mutant with respect to that of the 
wild type strain, with P values of < 0.05 considered significant. 
 
Whole genome sequencing (WGS) and variant analysis 
WGS of all 52 CNM isolates has been performed by Illumina at CDC (Tzeng et al., 
2017). The single contig genome of isolate CNM10 sequenced by Pacific Biosciences (PacBio) 
technology (Tzeng et al., 2017) was used as the reference genome in variant analysis. 
Polymyxin B resistant derivatives within the zone of inhibitions were recovered from seven 
CNM urethritis isolates (Table 1) were sequenced by MiSeq, yielding ~200X coverage of 
paired end 250-bp reads, assembled using SPAdes (Bankevich et al., 2012) and annotated by 
RAST(Aziz et al., 2008). The variant analysis service provided at www.patricbrc.org was 
utilized with the BWA-men (Li & Durbin, 2009) and SAMtools (Li et al., 2009) programs as 
the aligner and the SNP caller, respectively. The Illumina raw reads of the mutants were 
analyzed against a complete CNM10 genome as the reference. In addition, the assembled 
contigs were compared to the reference CNM10 genome using the genome comparator tool 
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available at the PUBMLST site (www.pubmlst.org) to identify allele differences. Variants 
were further confirmed by targeted PCR amplification and sequencing. 
 
Construction of lptA, mtrD/E, pilM, pilQ, and mutL mutants 
The CNM3 isolate was transformed with pKA314 (Tzeng et al., 2004) to generate the 
lptA::Ω(Sp) mutant, CNM3A. The mtrE:: Ω(Kn)  mutation was PCR amplified from the 
M7mtrE mutant with primers mrtDF2-ER and mtrE3R1-ER and the mtrD:: Ω(Sp) mutation 
from strain XZ134 (Tzeng et al., 2005) using primers mtrCF1 and mtrE3R1-ER. The purified 
PCR products were then used to transform CNM3. The lptA/mtrE double mutant, CNM3EA, 
was subsequently generated by transforming the mtrE mutant with pKA314.  A PCR product 
with the mutL::Ω(Sp) mutation was obtained with primers mutL1a and mutL1b (Richardson 
& Stojiljkovic, 2001) and used to transform the CNM3 isolate. 
The pilM::aphA3 mutation was created by the overlapping PCR method. Primer pairs 
of YT113 and pilM-5Ra and primer pairs of pilM-3Fa and pilMR2 were used to generate 
5’627-bp and 3’460-bp fragments, respectively.  The aphA3(Kn) cassette was amplified using 
primers aphA3-SmF and aphA3-SmR. First overlapping PCR was performed with the aphA3 
cassette and the 3’ fragment and then the resulting product was used for the second 
overlapping with the 5’ fragment.  The resulting construct deleted 756-bp pilM sequence.  
To introduce the pilQ point mutations found in the PmB heteroresistant mutants 
14R2 and 17R1, a construct with aphA3 cassette inserted 25 bp downstream of the pilQ stop 
codon was created by overlapping PCR.  Primers pilQ-F1 and pilQ-5RA3 were used to amplify 
an 1144-bp 5’ fragment from chromosomal DNAs of isolate 14R2 and 17R1 that carries the 
respective point mutations. The first overlapping PCR combined the 5’ fragment with the 
aphA3 cassette and the resulting product was subsequently used for overlapping PCR with a 
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3’ 849-bp fragment of primers pilQ-3FA3 and pilQ-3R2. The final ~2.8 kb product was used 
to transform either the CNM14 or CNM17 parental isolates as well as the CNM3 isolate and 
kanamycin resistant colonies were saved. PCR products were generated from the colonies 
and sequenced to determine whether the point mutations were recombined into the 
transformants.  Transformants with the desired point mutations or with a wild type 
sequence were saved for comparison. The CNM3DQ and CNM3AQ mutants were created by 
transformation of strains CNM3D and CNM3A with the overlapping PCR products carrying 
the 14R2 pilQ mutation. 
 
Determination of spontaneous mutation and slipped strand mispairing frequencies 
Overnight GC plate cultures were resuspended in GC broth and standardized by the 
OD550 readings. For spontaneous mutation rates, 40 µl of serial dilutions of cell suspensions 
were spotted onto GC plates for total CFU counts. Approximately 1010 cells were plated onto 
GC plates containing 3 µg rifampin/ml (Richardson & Stojiljkovic, 2001). Spontaneous 
rifampin mutation rates were obtained as the ratio of rifampin-resistant cells to the total 
number of cells. Serial dilutions of UROS-containing strains were plated on non-selective GC 
plates for total counts and on selective (60 µg/ml spectinomycin) plates for switch-on CFU 
counts. Frequencies of phase variation were determined as described previously (Alexander 
et al., 2004b) and are represented as medians of three independent measurements. 
Transformation efficiency  
Plate-grown meningococcal strains were suspended in GC broth supplemented with 
5 mM MgCl2. One μg of chromosomal DNA (tonB::ΩSp) from Nm strain NMB was added to 
aliquots (100 μl) of cell suspension at an OD550 of 1 and then incubated for 1 hr at 37oC.  Pre-
warmed GC broth with complete supplements (500 μl) and DNase I (2 units) was added and 
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the incubation continued for another 30 minutes. Serial dilutions were made and aliquots of 
50 μl were spotted onto non-selective GC plates and the colony forming units (cfu) 
determined after overnight growth. 500-μl of the transformation mixtures and 100-μl 
aliquots of 10-1 and 10-2 dilutions of the mutants and the parental strains, respectively, were 
plated onto selective (Sp) plates. The efficiencies were calculated as the ratio of cfu/ml from 
the selection plate to the cfu/ml of non-selective plates.  
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Table 1. Polymyxin resistant mutants derived from the US_NmUC isolates 
Mutant PmB MIC 
(parental) 
Gene Position Changesa 
Parent/mutant 
Outcomeb Transformation 
frequencyc 
(parental) 
3R3, 3R4, 
3R5, 3R6, 
3R7 
1,024  
(128) 
pilQ T167 ctTcg/ctcg fs F56S* <1.3×10
-8
  
(3.4×10
-4
) 
14R2 1,024  
(192) 
pilQ A2266 acc/Ccc T756P <4.9×10
-9
  
(1.9×10
-5
) 
17R1 1,024  
(128) 
pilQ A1465 acc/Ccc T489P 3.2×10
-7
  
(2.1×10
-5
) 
32R1,  
32R2 
1,024  
(128) 
pilQ G2229 ggg/gggG fs G743 → 815 aa <1.4×10
-8
  
(4.1×10
-5
) 
33R1 1,024  
(96) 
pilQ A1947 Aaaaaa/aaaaa fs AVLG/PSWG 
655* 
1.3×10
-7
  
(2.2×10
-5
) 
37R1 384  
(96) 
pilM A16 IS1655 insertion Disruption <3.9×10
-8
  
(3.6×10
-5
) 
45R2 384  
(128) 
pilM C126 caa/Taa fs Q43* <7.2×10
-9
  
(7.9×10
-5
) 
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a: For point mutation, the wildtype sequence is shown on the left and the mutant on the 
left. The changed nucleotide was in capital letter. 
b: Amino acid changes from the wild type to the mutant and the residue number are 
indicated. An asterisk indicates a stop codon immediately following the residue. The 
frameshift in 32R1 and 32R2 removed the original stop codon and yielded a larger PilQ 
protein. The lengths of PilQ and PilM proteins are 769 and 371, respectively. 
c: Transformation was performed using 1 µg chromosomal DNA carrying a tonB::Ω(Sp) 
mutation. Frequencies (n=3) were calculated as the ratio of SpR cfu/ml to total cfu/ml per 1 
µg DNA. The mutants with numbers in bold were transformable at low frequencies; while no 
transformants were recovered from the others. 
 
Table 2. Comparison of antibiotic resistance levels of the PmB heteroresistant mutant#  
Antibiotics 
CNM3 CNM3R4 MS11 CNG20 FA19 
E test (µg/ml) 
Colistin 53.3 ± 9.2 256** 256 48 32 
Penicillin G 0.22 ± 0.08 0.46 ± 0.10** 0.25 0.064 0.012 
ceftriaxone 0.002 ± 0.000 0.004 ± 0.001** 0.002 0.002 0.002 
Cefotaxime 0.01 ± 0.003 0.021 ± 0.004** 0.012 0.004 0.002 
Azithromycin 0.70 ± 011 0.85 ± 0.14 0.19 0.032 0.064 
Streptomycin 7.8 ± 0.7 10.9 ± 2.0** 1024 4 6 
Kanamycin 10.9 ± 2.0 14.3 ± 2.1** 8 8 4 
Chloramphenicol 0.63 ± 0.13 0.81 ± 0.18* 2 0.125 0.25 
Meropenem 0.3 ± 0.1 0.3 ± 0.1 0.064 0.094 0.064 
Tetracycline 0.19 ± 0.0 0.26 ± 0.1* 0.5 0.25 0.094 
Levofloxacin 0.008 ± 0.0 0.007 ± 0.0 0.004 0.002 0.003 
#. Data are presented as the mean ± standard deviation (N=3-8). The MIC values of 
antibiotics in bold are statistically different between CNM3 and 3R4 by student’s t test (**, p 
< 0.01; *, p < 0.05). A single data point is shown for each gonococcal strain as comparison. 
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Table 3. Comparison of antibiotic resistance levels of the PmB heteroresistant derivative in 
the mtrD or lptA mutant background 
Antibiotics 
CNM3D CNM3DQ CNM3A CNM3AQ 
E test (µg/ml) 
Penicillin G 0.053 ± 0.01 0.058 ± 0.01 0.079 ± 0.021 0.115 ± 0.018 
Chloramphenicol 0.38 ± 0.0 0.38 ± 0.0 0.38 ± 0.0 0.38 ± 0.0 
Tetracycline 0.182 ± 0.151 0.115 ± 0.018 0.094 ± 0.0 0.084 ± 0.017 
 #. Data are presented as the mean ± standard deviation (n=3).  
Table 4. Bacterial strains used in this study. 
Strains Description Source 
IR2781 N. meningitidis serogroup B strain NMB (Richardson & 
Stojiljkovic, 2001)
FM7 Non-encapsulated N. meningitidis serogroup C strain FAM18 This study 
M7 Non-encapsulated serogroup B strain IR2781 (Swartley & 
Stephens, 1994) 
GA18736 N. meningitidis serogroup W 2002 clinical isolate Laboratory collection
IR2855 N. meningitidis serogroup A clinical isolate (Richardson & 
Stojiljkovic, 2001)
IR5426 hpuB::UROS derivative of IR2855 (Alexander et al., 
2004b) 
CNM3 N. meningitidis US_NmUC isolate  (Tzeng et al., 2017) 
CNM8 N. meningitidis US_NmUC isolate (Tzeng et al., 2017) 
CNM3uros hpuB::UROS derivative of CNM3 This study 
3R4 N. meningitidis PmB heteroresistant derivative of CNM3 This study 
14R2 N. meningitidis PmB heteroresistant derivative of CNM14 This study 
17R1 N. meningitidis PmB heteroresistant derivative of CNM17 This study 
32R1 N. meningitidis PmB heteroresistant derivative of CNM32 This study 
32R2 N. meningitidis PmB heteroresistant derivative of CNM32 This study 
33R1 N. meningitidis PmB heteroresistant derivative of CNM33 This study 
37R1 N. meningitidis PmB heteroresistant derivative of CNM37 This study 
45R2 N. meningitidis PmB heteroresistant derivative of CNM45 This study 
CNM3-
14R2 
N. meningitidis pilQ mutation of 14R2 incorporated into 
CNM3
This study 
CNM3-
17R1 
N. meningitidis pilQ mutation of 17R1 incorporated into 
CNM3
This study 
CNM3L N. meningitidis CNM3/mutL::aphA3 This study 
CNM3E N. meningitidis CNM3 with mtrE:: Ω(Kn) mutation This study 
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CNM3D N. meningitidis CNM3 with mtrD::Ω(Sp) mutation This study 
CNM3A N. meningitidis CNM3 with lptA:: Ω(Sp) mutation This study 
CNM3EM N. meningitidis CNM3E with pilM:: aphA3 mutation This study 
CNM3DQ N. meningitidis with the pilQ mutation of 14R2 incorporated 
into CNM3D 
This study 
CNM3AQ N. meningitidis with the pilQ mutation of 14R2 incorporated 
into CNM3A 
This study 
FA1090 N. gonorrhoeae reference strain Laboratory collection 
FA19 N. gonorrhoeae reference strain Laboratory collection 
CNG20 N. gonorrhoeae urethritis isolate (Tzeng et al., 2017)
H041 MDR N. gonorrhoeae clinical isolate (Ohnishi et al., 2011) 
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Figure legends 
Figure 1. (A) E-test pictures of two US_NmUC isolates (CNM3 and CNM8), two non-
encapsulated Nm reference strains (M7 and FM7) and Ng reference strains GA1090. The 
arrow points to a heteroresistant colony in the zone of growth inhibition. (B) Population 
analysis profiling (PAP) assays of PmB with strains M7 (), CNM3 (), CNM8 (), FM7 () 
and FA1090 (). The CFU counts of plates without PmB were set as 100% for normalization. 
The dotted line indicates the limit of detection. Each PmB concentration was assayed in 
triplicate and the experiments were repeated at least three times. (C) PAP assays of colistin 
performed similarly to PmB PAP assays with strains CNM3 (), PmB heteroresistant mutant 
3R4 (), FM7 (), M7 () and FA1090 ().  Each concentration was tested in duplicates 
and the assays repeated twice. 
 
Figure 2. Sensitivity to LL-37 of the CNM3 clade isolate (gray) and its heteroresistant mutant 
3R4 (black). Bacterial cells were incubated with LL-37 in RPMI at the indicated 
concentrations for 30 min and the number of viable CFU were determined by plating onto 
GC agar plates. Each conditions were assayed in duplicate at least twice. The averages and 
standard deviations of two independent assays are presented. Student’s t test was used to 
determine the statistical significance of survival of the mutant with respect to that of the 
wild type strain (**, P < 0.01). 
 
Figure 3. PilQ expression determined by Western blots. Equal amounts of whole cell lysates 
were resolved on 8% SDS-PAGE gels and transferred to PVDF membranes. The membrane 
was probed with PilQ antisera (Tonjum et al., 1998). Lanes: 1, WT; 2, 3R4 (pilQ-frameshift); 
3, 37R1 (pilM::IS1655); 4, 45R2 (pilM-frameshift); 5, 14R2 (pilQ/T756P); 6, 17R1 
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(pilQ/T489P); 7, 32R1 (pilQ-frameshift); 8, 33R1 (pilQ-frameshift); 9, WT. The locations of 
PilQ multimer and monomer were marked on the right. Protein MW ladders were labeled 
on the left. 
 
Figure 4. (A) Population analysis profiling (PAP) assays of PmB resistance. Strains CNM3 (), 
its mutL (CNM3L, ) and mtrD (CNM3D, ) mutants and the mutator strain IR2855 () 
were compared. The CFU counts of plates without PmB were set as 100% for normalization. 
Each PmB concentration was assayed in triplicate and the experiments were repeated at 
least three times. The dotted line indicates the limit of detection. (B) PAP assays of colistin 
resistance. Strains CNM3 (), its mutL (CNM3L, ), mtrD (CNM3D, ) and heteroresistant 
mutant 3R4 () were examined analogously to the PmB PAP assays.  
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